Our Services
Medical Information
Helpful Resources
Published on: 9/14/2026
Farxiga (dapagliflozin) does not have a harmful drug-drug interaction with metformin, and the two are often prescribed together, but combining Farxiga with insulin or insulin-stimulating drugs raises the risk of low blood sugar, so insulin doses may need to be lowered. Adults over 65 also face a higher chance of dehydration, low blood pressure, dizziness, urinary or genital infections, and reduced kidney function, which is why kidney labs and hydration matter more with age. Rare but serious risks such as ketoacidosis with near-normal glucose can occur, especially during illness, fasting, or surgery. Several factors, including your kidney function, other medications, and symptoms to watch for, change the answer for each person, so see below to understand more before adjusting anything.
If you are noticing dizziness, unusual thirst, frequent urination, shakiness, nausea, or signs of infection while on these medications, a free, instant, online symptom check can help you sort out what may be driving your symptoms and how urgently you should act, giving you clear, personalized next steps and better questions to bring to your doctor.
Last reviewed for medical accuracy: 09/13/2026
As we age, managing type 2 diabetes often means combining medications such as Farxiga (dapagliflozin), metformin and/or insulin. It’s natural to ask whether these medicines interact badly, especially after age 65. Below is an evidence-based look at how Farxiga works with metformin and insulin, what to watch for, and practical tips to stay safe and in control.
Current clinical data and prescribing information show:
That said, combining these medications requires attention to additive effects rather than classic “bad interactions.”
Hypoglycemia Risk
Volume Depletion & Blood Pressure
Kidney Function
Genital and Urinary Tract Infections
Weight Loss and Nutritional Status
Reach out promptly if you notice:
For general concerns or mild symptoms, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance before or after seeing your healthcare team:
https://ubiehealth.com/
For most adults over 65, the benefits of adding Farxiga to metformin and/or insulin outweigh the risks—provided there’s close follow-up and attention to side effects.
Farxiga does not have a classic harmful interaction with metformin or insulin. Instead, the focus is on:
Managing type 2 diabetes after 65 is a team effort between you and your healthcare providers. Always report new or worsening symptoms, and never hesitate to ask questions about your medications.
If you experience life-threatening or serious symptoms—such as loss of consciousness, severe dizziness, chest pain or difficulty breathing—seek emergency care or contact your doctor immediately. For less urgent concerns, a quick consult with your care team can keep your treatment on track and safe.
Speak to your doctor before making any changes to your diabetes medications. Your healthcare provider knows your personal health history best and can tailor the plan that’s right for you.
(References)
* Johnston R, Uthman O, Cummins E, Clar C, Royle P, Colquitt J, Tan BK, Clegg A, Shantikumar S, Court R, O'Hare JP, McGrane D, Holt T, Waugh N. Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation. Health Technol Assess. 2017 Jan;21(2):1-218. doi: 10.3310/hta21020. PMID: 28105986; PMCID: PMC5292646.
* Dhillon S. Dapagliflozin: A Review in Type 2 Diabetes. Drugs. 2019 Jul;79(10):1135-1146. doi: 10.1007/s40265-019-01148-3. PMID: 31236801; PMCID: PMC6879440.
* Comparison chart: SGLT2 inhibitors. Med Lett Drugs Ther. 2020 Nov 16;62(1611):e2-e4. Epub 2020 Nov 16. PMID: 33429417.
* Elkind-Hirsch KE, Chappell N, Seidemann E, Storment J, Bellanger D. Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2021 Sep 27;106(10):3019-3033. doi: 10.1210/clinem/dgab408. PMID: 34097062.
* Drugs for type 2 diabetes. Med Lett Drugs Ther. 2022 Nov 14;64(1663):177-184. PMID: 36384763.
* Sahay RK, Giri R, Shembalkar JV, Gupta SK, Mohan B, Kurmi P, Kumar SR, Sawardekar VM, Mishra A, Murthy LS, Arya VV, Sonawane AR, Soni PN, Gofne SK, Karnawat SR, Rajurkar MN, Patel PM, Lakhwani LK, Mehta SC, Joglekar SJ. Fixed-Dose Combination of Dapagliflozin + Sitagliptin + Metformin in Patients with Type 2 Diabetes Poorly Controlled with Metformin: Phase 3, Randomized Comparison with Dual Combinations. Adv Ther. 2023 Jul;40(7):3227-3246. doi: 10.1007/s12325-023-02523-z. Epub 2023 May 31. PMID: 37258803.
* Cuatrecasas G, De Cabo F, Coves MJ, Patrascioiu I, Aguilar G, Cuatrecasas G, March S, Calbo M, Rossell O, Balfegó M, Benito C, Di Gregorio S, Garcia Lorda P, Muñoz E. Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with obesity. Sci Rep. 2024 May 11;14(1):10832. doi: 10.1038/s41598-024-61590-6. Epub 2024 May 11. PMID: 38734755; PMCID: PMC11088615.
* Triplitt C, Cersosimo E, Alatrach M, Adams J, Hansis-Diarte A, Baskoy G, Gastaldelli A, Chavez-Velazquez A, DeFronzo RA. Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes. Diabetes Care. 2025 Sep 1;48(9):1545-1552. doi: 10.2337/dc25-0490. PMID: 40627548; PMCID: PMC12368385.
* Attia N, Al Noaim K, Mustafa M, Al Fifi SH, Al Alwan I, Thalange N, Babiker A. The Use of Dapagliflozin in the Treatment of Children With Severe Insulin Resistance. Pediatr Diabetes. 2025;2025:6859764. doi: 10.1155/pedi/6859764. Epub 2025 Dec 20. PMID: 41424588; PMCID: PMC12717530.
* Chee YJ, Acharyya S, Liew H, Seow CJ, Goh LL, Boehm BO, Dalan R. First-Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial. Diabetes Obes Metab. 2026 Sep;28(9):8568-8580. doi: 10.1111/dom.71056. Epub 2026 Jul 3. PMID: 42396722; PMCID: PMC13449050.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.